APO-Norflox 400 mg (2015-08-25)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| MC8181 | APO-Norflox 400 mg | - Recalling Firm
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
- Marketing Authorization Holder
- Apotex Inc.
- 150 Signet Drive
- Toronto
- M9L 1T9
- Ontario
- CANADA
| Tablet | DIN 02229524 | Norfloxacin 400 mg |
Affected Products
APO-Norflox 400 mg
Levels of excipients crospovidone and magnesium stereate do not meet the quantities specified in the regulatory filing.
Wholesalers, Distributors, and Retailers